VIRX

Q: What is the price of Viracta Therapeutics (VIRX) today?

The current price of Viracta Therapeutics (VIRX) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.009800 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Viracta Therapeutics (VIRX) pay dividends?

Viracta Therapeutics (VIRX) did not pay dividends over the past year.

Viracta Therapeutics Inc.

Price

$ -

return (12m)

0.00%

p/e

-0.01

p/bv

-0.06

DIVIDEND YIELD

0.00%

VIRX price

Viracta Therapeutics

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment VIRX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals VIRX

review the fundamentals of Viracta Therapeutics shares

P/E

-0.01

Sector: -3.80 Industry: -3.80

P/S (PSR)

Sector: -4.18 Industry: -4.18

P/BV

-0.06

Sector: 1.92 Industry: 1.92

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-197.13%

Sector: -65.32% Industry: -65.32%

ROE

653.93%

Sector: -66.07% Industry: -66.07%

ROIC

-225.49%

Sector: -2,920.39% Industry: -2,920.39%

NET MARGIN

0.00%

Sector: -40.34% Industry: -40.34%

GROSS MARGIN

0.00%

Sector: 36.85% Industry: 36.85%

OPERATING MARGIN

0.00%

Sector: -39.20% Industry: -39.20%

EV/EBITDA

-0.01

Sector: -3.89 Industry: -3.89

EV/EBIT

-0.01

Sector: -3.98 Industry: -3.98

PRICE-TO-ASSETS

0.02

Sector: 1.42 Industry: 1.42

BVPS

-0.17

Sector: 1.86 Industry: 1.86

EPS

-1.08

Sector: -2.12 Industry: -2.12

EQUITY-TO-ASSETS RATIO

-0.30

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

1.30

Sector: 0.40 Industry: 0.40

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-17.72%

Sector: - Industry: -

Fundamentals VIRX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	27.58	7.15	25.92%	2.18%	$ 580.26 B	21.83%
PFE	19.91	1.65	8.29%	6.56%	$ 149.16 B	11.83%
ABBV	110.89	-60.96	-54.98%	2.96%	$ 403.08 B	5.79%
NVO	65.46	40.20	61.41%	4.25%	$ 195.21 B	37.07%
MRK	32.94	6.41	19.45%	2.79%	$ 294.29 B	13.59%
AZN	26.65	5.84	21.93%	1.79%	$ 276.88 B	17.19%
GILD	16.93	6.66	39.33%	2.54%	$ 155.98 B	30.99%
BMY	16.00	5.79	36.19%	4.38%	$ 116.43 B	15.01%
ZTS	12.70	10.39	81.75%	2.59%	$ 33.58 B	27.79%
REGN	14.39	2.03	14.08%	0.59%	$ 63.66 B	29.65%
HALO	23.51	37.34	158.82%	0.00%	$ 8.20 B	23.13%
AMGN	24.59	20.87	84.87%	2.76%	$ 191.81 B	20.96%
MCK	20.09	-114.69	-570.98%	0.40%	$ 95.65 B	1.18%
HRMY	13.72	2.20	16.00%	0.00%	$ 2.00 B	16.20%
VRTX	26.05	5.84	22.41%	0.00%	$ 113.01 B	35.51%
CAH	33.83	-19.69	-58.20%	0.91%	$ 52.60 B	0.62%
ADMA	11.72	4.96	42.37%	0.00%	$ 1.94 B	32.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

VIRX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Viracta Therapeutics

Viracta Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

19 years

Founded: 2007

2021

Time since IPO - 5 years

-

Employees

Viracta Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $392.00 Thousand, with shareholders equity totaling $-6.62 Millions.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, Viracta Therapeutics Inc. reported $- in revenue, generating net income of $-43.29 Millions.

Key financial metrics include a P/E ratio of -0.01, a price-to-book (P/B) ratio of -0.06, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker VIRX.

Market cap

$ 392.00 Thousand

Net worth

$ -6.62 Millions

$ -6,620,000.00

Assets

$ 21.96 Millions

$ 21,960,000.00

Total Shares Outstanding

40.00 Millions

40,000,000

Average Daily Trading Volume

$ -

Sector

Health Care

Industry

Biotechnology

VIRX

VIRX revenue and profits

Financial Results VIRX

DRAG THE FRAME TO SEE MORE DATA

VIRX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 784.05 8,21% (12M)

P/E

20.09

0.40%

ROE

-570.98%

P/BV

-114.69

CAH - Cardinal Health

$ 223.85 40,59% (12M)

P/E

33.83

0.91%

ROE

-58.20%

P/BV

-19.69

JNJ - Johnson & Johnson

$ 240.87 57,17% (12M)

P/E

27.58

2.18%

ROE

25.92%

P/BV

7.15

MRK - Merck & Co.

$ 119.05 52,03% (12M)

P/E

32.94

2.79%

ROE

19.45%

P/BV

6.41

AZN - AstraZeneca

$ 178.75 28,14% (12M)

P/E

26.65

1.79%

ROE

21.93%

P/BV

5.84

ABBV - AbbVie

$ 227.73 22,97% (12M)

P/E

110.89

2.96%

ROE

-54.98%

P/BV

-60.96

PFE - Pfizer

$ 26.21 14,30% (12M)

P/E

19.91

6.56%

ROE

8.29%

P/BV

1.65

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 784.05 8,21% (12 M)

P/L

20.09

0.40%

ROE

-570.98%

P/VP

-114.69

CAH - Cardinal Health

$ 223.85 40,59% (12 M)

P/L

33.83

0.91%

ROE

-58.20%

P/VP

-19.69

JNJ - Johnson & Johnson

$ 240.87 57,17% (12 M)

P/L

27.58

2.18%

ROE

25.92%

P/VP

7.15

MRK - Merck & Co.

$ 119.05 52,03% (12 M)

P/L

32.94

2.79%

ROE

19.45%

P/VP

6.41

AZN - AstraZeneca

$ 178.75 28,14% (12 M)

P/L

26.65

1.79%

ROE

21.93%

P/VP

5.84

ABBV - AbbVie

$ 227.73 22,97% (12 M)

P/L

110.89

2.96%

ROE

-54.98%

P/VP

-60.96

PFE - Pfizer

$ 26.21 14,30% (12 M)

P/L

19.91

6.56%

ROE

8.29%

P/VP

1.65

Frequently Asked Questions

What is the price of Viracta Therapeutics (VIRX) today?

The current price of Viracta Therapeutics (VIRX) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.009800 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Viracta Therapeutics (VIRX) pay dividends?

Viracta Therapeutics (VIRX) did not pay dividends over the past year.

Is Viracta Therapeutics (VIRX) a good investment?

Viracta Therapeutics (VIRX) is currently trading at $ 0.00 with a P/E ratio of -0.01. This represents a -55% premium compared to its historical average P/E. Over the past year, the stock has gained 0 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Viracta Therapeutics (VIRX) stock?

You can buy Viracta Therapeutics (VIRX) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol VIRX and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Viracta Therapeutics (VIRX) yield today?

Over the past month, Viracta Therapeutics (VIRX) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Viracta Therapeutics (VIRX) today at the current price of $ 0.00 your total investment would be $ 0.00.

Based on historical performance, the investment would have grown to approximately:

$ 0.00 after 1 year
$ 0.00 after 5 years
$ 0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

VIRX

Viracta Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment VIRX

review the fundamentals of Viracta Therapeutics shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Viracta Therapeutics

Viracta Therapeutics Inc.

United States

19 years

2021

-

PROFIT X PRICE VIRX

Financial Results VIRX

VIRX cash flow

Asset, Revenue and Profit Growth - VIRX

VIRX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

PFE - Pfizer

Frequently Asked Questions